On June 29, 2026, Mayukh Sukhatme, President & CIO of Roivant Sciences Ltd. (ROIV), executed two significant sales of the company's shares, totaling approximately $34.10 million. These transactions involved the sale of 500,000 shares at an average price of $34.11 per share.
This activity follows other recent sales by company insiders. Earlier in June, Eric Venker sold a combined total of 400,000 shares across multiple transactions, amounting to approximately $12.68 million.
While insider sales can be attributed to various personal financial strategies, including diversification or tax planning, the cumulative nature of these recent transactions by multiple executives may attract investor attention.